Figure 8.
(A) Structures of the designed fentanyl-based MOR/FAAH/MAGL MTAs. (B) Structures of selected FAAH/MAGL inhibitors. In red marked is carbamate/urea substructures.
(A) Structures of the designed fentanyl-based MOR/FAAH/MAGL MTAs. (B) Structures of selected FAAH/MAGL inhibitors. In red marked is carbamate/urea substructures.